Resumen

OSCANOA ESPINOZA, Teodoro Julio. Seguridad de los Inhibidores de la bomba de protones. Rev. gastroenterol. Perú, ene./mar. 2011, vol.31, no.1, p.49-55. ISSN 1022-5129.

Proton Pump Inhibitors (PPI) are consumed by millions of people around the world, either by prescription or self-medication, some medications of this group are Over-the-counter (OTC) medicines. PPIs have been associated with hypergastrinemia, rebound acid hypersecretion, malabsorption, osteoporosis and infections. This is an updated review of clinical pharmacology aspects of IPBS, with emphasis on safety aspects.

Palabras llave: Adverse Events; Proton Pump Inhibitors.